Developmental BiologybioRxivPreprint
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 iPSC-derived neural cells
Nicole R. West, Mattias F. Lindberg, Julien Dairou…·Anita Bhattacharyya
This study shows that Leucettinib-21 reduces DYRK1A activity in human trisomy 21 neural cells, supporting its potential as a therapeutic for Down syndrome.
DOI 10.64898/2026.02.05.704014